High-Intensity Interval Training is Associated with Improved Long-Term Survival in Heart Failure Patients

Chih-Chin Hsu1,2,3, Tieh-Cheng Fu4,5,6, Shin-Sheng Yuan7

  • 1Department of Physical Medicine and Rehabilitation, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan. steele0618@gmail.com.

Insights

High-intensity interval training (HIIT) significantly improves survival in heart failure (HF) patients by increasing peak oxygen consumption (VO2peak) and improving left ventricle dimensions. This exercise intervention offers a promising strategy for enhancing outcomes in HF management.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Heart Failure Management

Background:

  • Heart failure (HF) is a chronic condition associated with significant mortality.
  • Exercise-based interventions are explored to improve outcomes in HF patients.
  • Left ventricle (LV) dimensions and peak oxygen consumption (VO2peak) are key indicators of HF prognosis.

Purpose of the Study:

  • To investigate the impact of high-intensity interval training (HIIT) on LV dimensions and survival in HF patients.
  • To assess the relationship between changes in VO2peak, LV geometry, and mortality risk in HF.

Main Methods:

  • A matched-control cohort study involving 202 HF patients (2009-2016).
  • Comparison between a multidisciplinary disease management program (MDP) group (n=101) and a HIIT group (n=101) completing 36 sessions.
  • Assessment of VO2peak and LV geometry during an 8-year follow-up; determination of 5-year all-cause mortality.

Main Results:

  • HIIT group showed a 14-20% increase in VO2peak; each 1-mL/kg/min VO2peak increase correlated with a 58% improvement in 5-year mortality.
  • Increased LV end-systolic diameter (LVESD) was significantly associated with higher mortality (p=0.0198).
  • HIIT participants demonstrated significantly improved 8-month survival (p=0.044) compared to the non-exercise group.
  • HF patients with VO2peak ≥14.0 mL/kg/min and LVESD <44 mm had a superior 5-year survival rate (98.2%) versus those with poorer metrics (57.3%).

Conclusions:

  • HIIT is associated with improved VO2peak and favorable LV geometry changes in HF patients.
  • Both increased VO2peak and decreased LVESD induced by HIIT are linked to enhanced survival rates in heart failure.
  • HIIT represents a valuable therapeutic strategy for improving long-term outcomes in heart failure management.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
837
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
776
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
301
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
893
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
256